Tradestie Institutional Equity Comparison Engine

OKYO vs MAIA โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

MAIA Overall Edge

MAIA Captures Institutional Edge (2โ€“1 Pillars ยท 3โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to MAIA Biotechnology, Inc. (MAIA) driven by superior Valuation, Momentum & Technical while OKYO counters with relative strength in Growth & Margin. Fundamentally, OKYO trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus MAIA at 1.2x Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, OKYO sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against MAIA sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner MAIA
OKYO N/M vs MAIA 1.2x Fwd P/E
Growth & Margin Winner OKYO
Op Margin 0.0% vs 0.0% ยท YoY +0.0% vs +0.0%
Momentum & Technical Winner MAIA
1Y -47.0% vs +20.6% ยท 52W Pos 3% vs 10%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
OKYO NASDAQ
OKYO Pharma Limited Ordinary Shares
Biological Products, (No Diagnostic Substances)
$1.07
-7.76% 1D
Market Cap $62.7M
1M Return -27.21%
1Y Return -47.03%
Forward P/E N/M
Unified AI Score
42.8 / 100 HOLD
Tech 38.0 Fund 54.0 Flow 50.0 Mom 45.0
MAIA NYSE American
MAIA Biotechnology, Inc.
Pharmaceutical Preparations
$1.11
-2.63% 1D
Market Cap $68.5M
1M Return -1.77%
1Y Return +20.65%
Forward P/E 1.2x
Unified AI Score
37.6 / 100 SELL
Tech 40.0 Fund 38.0 Flow 50.0 Mom 44.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: OKYO -47.03% MAIA +20.65% Spread: +67.68 pp (MAIA Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
OKYO TTM Op. Margin: 0.0% MAIA TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on OKYO vs MAIA. Trailing 12-month operating profitability (OKYO 0.0% vs MAIA 0.0%) and valuation multiples (OKYO N/M vs MAIA 1.2x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: OKYO (3) vs MAIA (3)
Institutional Metric OKYO MAIA Criterion Row Winner
Market Capitalization Scale $62.7M $68.5M Larger Scale Tie
Trailing P/E Ratio Valuation N/M 1.2x Lower Multiple MAIA
Forward P/E Ratio Valuation N/M 1.2x Lower Multiple MAIA
Revenue Growth (YoY) Growth +0.0% +0.0% Higher Growth Tie
Operating Margin (TTM) Profitability 0.0% 0.0% Higher Margin Tie
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -263.8% -341.5% Higher ROE OKYO
52-Week Range Position Momentum 3% ($1โ€“$3) 10% ($1โ€“$3) Stronger Trend MAIA
Beta / 30D Volatility Risk Regime 1.00ฮฒ ยท 76% Vol 1.65ฮฒ ยท 108% Vol Lower Realized Risk OKYO
Unified Institutional Score Composite Signal 42.8 / 100 (HOLD) 37.6 / 100 (SELL) Higher Composite OKYO

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full OKYO vs MAIA Buy Guide
OKYO UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live OKYO Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
MAIA UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live MAIA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither OKYO nor MAIA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.